Table 2.
Controls (n=25) | Patients (n=17) | All (n=42) | ||||
---|---|---|---|---|---|---|
r (r2) with PRESS |
CoV (%) |
r (r2) with PRESS |
CoV (%) |
r (r2) with PRESS |
CoV (%) |
|
PRESS | --- | 11.9 | --- | 9.8 | --- | 10.9 |
MP-Off | 0.88 (0.77) | 9.2 | 0.76 (0.58) | 8.9 | 0.84 (.70) | 9.0 |
MP-Diff | 0.16 (0.03)** | 10.1 | 0.44 (0.20)a | 8.8 | 0.26 (.07)** | 9.7 |
MP-Diff-PI | 0.36 (0.13)** | 10.2 | 0.49 (0.24)a | 11.0 | 0.40 (.16)** | 11.0 |
Abbreviations as in Table 1; MP-Diff-PI = MEGA-PRESS difference spectra with glx/creatine quantified by peak integration, all others are glx/creatine from LCModel fits. Note that since peak integration cannot estimate glutamate separately from glutamine, peak integration values are only shown in Table 2.
lower than PRESS vs MP-Off correlation, p < .0001
lower than PRESS vs MP-Off correlation, p < .05
NS, p ≤ .14